Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Cardiovascular disease care fragmentation in kidney transplantation: a call for action.

Rangaswami J, Bangalore S, Kaplan B, Birdwell KA, Wiseman AC, McCullough PA, Dadhania DM.

Kidney Int. 2019 Sep;96(3):568-571. doi: 10.1016/j.kint.2019.04.042. Epub 2019 Jun 10. No abstract available.

PMID:
31349974
2.

Simultaneous Liver-Kidney Transplant: Long-Term Management (Steroid Withdrawal and Safety Net Patients).

Wiseman AC.

Clin Liver Dis (Hoboken). 2019 Jul 2;13(6):176-179. doi: 10.1002/cld.814. eCollection 2019 Jun. Review. No abstract available.

3.

Risk of ESKD in Older Live Kidney Donors with Hypertension.

Al Ammary F, Luo X, Muzaale AD, Massie AB, Crews DC, Waldram MM, Qadi MA, Garonzik-Wang J, Henderson ML, Brennan DC, Wiseman AC, Lindrooth RC, Snyder JJ, Coresh J, Segev DL.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.

PMID:
31239252
4.

The changing landscape of live kidney donation in the United States from 2005 to 2017.

Al Ammary F, Bowring MG, Massie AB, Yu S, Waldram MM, Garonzik-Wang J, Thomas AG, Holscher CM, Qadi MA, Henderson ML, Wiseman AC, Gralla J, Brennan DC, Segev DL, Muzaale AD.

Am J Transplant. 2019 Sep;19(9):2614-2621. doi: 10.1111/ajt.15368. Epub 2019 May 3.

PMID:
30903733
5.

Academic achievement and employment in young adults with end-stage kidney disease.

Murray PD, Brodermann MH, Gralla J, Wiseman AC, Harden PN.

J Ren Care. 2019 Mar;45(1):29-40. doi: 10.1111/jorc.12261. Epub 2018 Oct 2.

PMID:
30277317
6.

Defining kidney allograft benefit from successful pancreas transplant: separating fact from fiction.

Wiseman AC, Stites E, Kennealey P.

Curr Opin Organ Transplant. 2018 Aug;23(4):448-453. doi: 10.1097/MOT.0000000000000547. Review.

PMID:
29878910
7.

Protecting Donors and Safeguarding Altruism in the United States: The Living Donor Protection Act.

Wiseman AC.

Clin J Am Soc Nephrol. 2018 May 7;13(5):790-792. doi: 10.2215/CJN.13681217. Epub 2018 Mar 9. No abstract available.

8.

Live donor kidney - PAK versus SPK: how to decide?

Stites E, Wiseman AC.

Curr Opin Organ Transplant. 2017 Aug;22(4):377-381. doi: 10.1097/MOT.0000000000000435. Review.

PMID:
28538038
9.

De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive Regimens.

Mithani Z, Gralla J, Adebiyi O, Klem P, Cooper JE, Wiseman AC.

Exp Clin Transplant. 2018 Feb;16(1):23-30. doi: 10.6002/ect.2016.0234. Epub 2017 Mar 22.

10.

Financial Incompatibility and Paired Kidney Exchange: Walking a Tightrope or Blazing a Trail?

Wiseman AC, Gill JS.

Am J Transplant. 2017 Mar;17(3):597-598. doi: 10.1111/ajt.14183. Epub 2017 Jan 24. No abstract available.

11.

Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.

Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A.

Am J Transplant. 2017 Apr;17(4):901-911. doi: 10.1111/ajt.14173. Epub 2017 Feb 2.

12.

Current status of pancreas transplantation.

Stites E, Kennealey P, Wiseman AC.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):563-569. Review.

PMID:
27653421
13.

Multiorgan transplantation.

Stites E, Wiseman AC.

Transplant Rev (Orlando). 2016 Oct;30(4):253-60. doi: 10.1016/j.trre.2016.04.002. Epub 2016 Jul 17. Review.

PMID:
27515042
14.

Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.

Adebiyi OO, Gralla J, Klem P, Freed B, Davis S, Wiseman AC, Cooper JE.

Am J Transplant. 2016 Dec;16(12):3458-3467. doi: 10.1111/ajt.13848. Epub 2016 Jun 15.

15.

APOL1 Polymorphisms in a Deceased Donor and Early Presentation of Collapsing Glomerulopathy and Focal Segmental Glomerulosclerosis in Two Recipients.

Shah PB, Cooper JE, Lucia MS, Boils C, Larsen CP, Wiseman AC.

Am J Transplant. 2016 Jun;16(6):1923-1927. doi: 10.1111/ajt.13748. Epub 2016 Mar 29.

16.

Simultaneous Liver-Kidney Transplant: Too Many or Just Enough?

Sung RS, Wiseman AC.

Adv Chronic Kidney Dis. 2015 Sep;22(5):399-403. doi: 10.1053/j.ackd.2015.06.005. Review.

PMID:
26311602
17.

Immunosuppressive Medications.

Wiseman AC.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):332-43. doi: 10.2215/CJN.08570814. Epub 2015 Jul 13. Review.

18.

Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know.

Wiseman AC.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):923-5. doi: 10.2215/CJN.03800415. Epub 2015 May 15. No abstract available.

19.

High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction.

Cooper JE, Gralla J, Klem P, Chan L, Wiseman AC.

Transplantation. 2014 Jun 27;97(12):1253-9. doi: 10.1097/01.TP.0000443226.74584.03.

PMID:
24937199
20.

First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection.

Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, Getts DR.

Am J Transplant. 2014 Jun;14(6):1346-55. doi: 10.1111/ajt.12698. Epub 2014 Apr 17.

21.

Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.

Kurian SM, Williams AN, Gelbart T, Campbell D, Mondala TS, Head SR, Horvath S, Gaber L, Thompson R, Whisenant T, Lin W, Langfelder P, Robison EH, Schaffer RL, Fisher JS, Friedewald J, Flechner SM, Chan LK, Wiseman AC, Shidban H, Mendez R, Heilman R, Abecassis MM, Marsh CL, Salomon DR.

Am J Transplant. 2014 May;14(5):1164-72. doi: 10.1111/ajt.12671. Epub 2014 Apr 11.

22.

The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patients.

Getts DR, Kramer WG, Wiseman AC, Flechner SM.

Clin Pharmacokinet. 2014 Jul;53(7):649-57. doi: 10.1007/s40262-014-0138-1.

PMID:
24668001
23.

The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression.

Gralla J, Le CN, Cooper JE, Wiseman AC.

Clin Transplant. 2014 Mar;28(3):292-8. doi: 10.1111/ctr.12311. Epub 2014 Jan 30.

PMID:
24476453
25.

Acute kidney injury in kidney transplantation.

Cooper JE, Wiseman AC.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):698-703. doi: 10.1097/MNH.0b013e328365b388. Review.

PMID:
24076557
26.

Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials.

Cooper M, Wiseman AC, Zibari G, McCague K, Kim Y, Geissler F, Nashan B.

Clin Transplant. 2013 Nov-Dec;27(6):E625-35. doi: 10.1111/ctr.12223. Epub 2013 Sep 6.

PMID:
24033455
27.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML.

Ustun C, Wiseman AC, Defor TE, Yohe S, Linden MA, Oran B, Burke M, Warlick E, Miller JS, Weisdorf D.

Bone Marrow Transplant. 2013 Nov;48(11):1415-20. doi: 10.1038/bmt.2013.124. Epub 2013 Aug 12. Erratum in: Bone Marrow Transplant. 2013 Nov;48(11):1488.

PMID:
23933764
28.

Kidney transplant options for the diabetic patient.

Wiseman AC.

Transplant Rev (Orlando). 2013 Oct;27(4):112-6. doi: 10.1016/j.trre.2013.07.002. Epub 2013 Aug 6. Review.

PMID:
23927899
29.
30.

The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes.

Wiseman AC, Huang E, Kamgar M, Bunnapradist S.

Nephrol Dial Transplant. 2013 Apr;28(4):1047-58. doi: 10.1093/ndt/gfs582. Epub 2013 Jan 25.

PMID:
23355627
31.

Donor specific antibodies before and after kidney transplant: the University of Colorado Experience.

Cooper JE, Gralla J, Adebiyi O, Wiseman AC, Chan L.

Clin Transpl. 2013:407-12.

PMID:
25095536
32.

The effect of everolimus versus mycophenolate upon proteinuria following kidney transplant and relationship to graft outcomes.

Wiseman AC, McCague K, Kim Y, Geissler F, Cooper M.

Am J Transplant. 2013 Feb;13(2):442-9. doi: 10.1111/j.1600-6143.2012.04334.x. Epub 2012 Dec 3.

33.

Removing financial disincentives to organ donation: an acceptable next step?

Wiseman AC.

Clin J Am Soc Nephrol. 2012 Dec;7(12):1917-9. doi: 10.2215/CJN.11021012. Epub 2012 Nov 15. No abstract available.

34.

Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes.

Wiseman AC, Gralla J.

Clin J Am Soc Nephrol. 2012 Apr;7(4):656-64. doi: 10.2215/CJN.08310811. Epub 2012 Feb 16.

35.

Pancreas transplant options for patients with type 1 diabetes mellitus and chronic kidney disease: simultaneous pancreas kidney or pancreas after kidney?

Wiseman AC.

Curr Opin Organ Transplant. 2012 Feb;17(1):80-6. doi: 10.1097/MOT.0b013e32834ee73a. Review.

PMID:
22186096
36.

Trends in immune function assay (ImmuKnow; Cylex™) results in the first year post-transplant and relationship to BK virus infection.

Gralla J, Huskey J, Wiseman AC.

Nephrol Dial Transplant. 2012 Jun;27(6):2565-70. doi: 10.1093/ndt/gfr675. Epub 2011 Dec 13.

PMID:
22167591
37.

Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.

Cooper JE, Gralla J, Cagle L, Goldberg R, Chan L, Wiseman AC.

Transplantation. 2011 May 27;91(10):1103-9. doi: 10.1097/TP.0b013e3182139da1.

PMID:
21403588
38.

Chronic viral hepatitis in kidney transplantation.

Huskey J, Wiseman AC.

Nat Rev Nephrol. 2011 Mar;7(3):156-65. doi: 10.1038/nrneph.2010.192. Epub 2011 Feb 1. Review.

PMID:
21283138
39.

Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.

Cooper JE, Gralla J, Chan L, Wiseman AC.

Clin Transpl. 2011:359-64.

PMID:
22755431
40.

Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.

Huskey J, Gralla J, Wiseman AC.

Clin J Am Soc Nephrol. 2011 Feb;6(2):423-9. doi: 10.2215/CJN.04210510. Epub 2010 Nov 18.

41.

Long-term impact of donor-recipient size mismatching in deceased donor kidney transplantation and in expanded criteria donor recipients.

Goldberg RJ, Smits G, Wiseman AC.

Transplantation. 2010 Oct 27;90(8):867-74. doi: 10.1097/TP.0b013e3181f24e75.

PMID:
20697325
42.

Culture of impure human islet fractions in the presence of alpha-1 antitrypsin prevents insulin cleavage and improves islet recovery.

Loganathan G, Dawra RK, Pugazhenthi S, Wiseman AC, Sanders MA, Saluja AK, Sutherland DE, Hering BJ, Balamurugan AN.

Transplant Proc. 2010 Jul-Aug;42(6):2055-7. doi: 10.1016/j.transproceed.2010.05.119.

43.

Preemptive retransplant for BK virus nephropathy without concurrent transplant nephrectomy.

Cooper JE, Huskey J, Chan L, Wiseman AC.

Transplantation. 2010 Aug 15;90(3):331-2. doi: 10.1097/TP.0b013e3181dcfe52. No abstract available.

PMID:
20683427
44.

The role of kidney-pancreas transplantation in diabetic kidney disease.

Wiseman AC.

Curr Diab Rep. 2010 Oct;10(5):385-91. doi: 10.1007/s11892-010-0136-0. Review.

45.

An analysis of the lack of donor pancreas utilization from younger adult organ donors.

Wiseman AC, Wainright JL, Sleeman E, McBride MA, Baker T, Samana C, Stock P.

Transplantation. 2010 Sep 15;90(5):475-80. doi: 10.1097/TP.0b013e3181e9fea4. Review.

PMID:
20595930
46.

The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression.

Gralla J, Wiseman AC.

Transplantation. 2010 Sep 27;90(6):639-44. doi: 10.1097/TP.0b013e3181ea6788.

PMID:
20595929
47.

Novel immunosuppressive agents in kidney transplantation.

Cooper JE, Wiseman AC.

Clin Nephrol. 2010 May;73(5):333-43. Review.

PMID:
20420793
48.

Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases.

Cooper JE, Wiseman AC, Chan L.

Clin Transpl. 2010:415-20. No abstract available.

PMID:
21698838
49.

Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.

Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.

Transplantation. 2009 Oct 15;88(7):891-6. doi: 10.1097/TP.0b013e3181b6f38c.

PMID:
19935460
50.

Standard criteria donor pancreas donation status is associated with improved kidney transplant outcomes.

Weiss AS, Smits G, Wiseman AC.

Clin Transplant. 2009 Sep-Oct;23(5):732-9. doi: 10.1111/j.1399-0012.2009.01064.x. Epub 2009 Sep 1.

PMID:
19732097

Supplemental Content

Loading ...
Support Center